US Stock MarketDetailed Quotes
TIL Instil Bio
- 26.1500
- +1.3900+5.61%
Close Nov 22 16:00 ET
170.65MMarket Cap-2262P/E (TTM)
26.7700High24.0900Low91.17KVolume24.6900Open24.7600Pre Close2.35MTurnover3.81%Turnover RatioLossP/E (Static)6.53MShares92.000052wk High0.97P/B62.51MFloat Cap6.060052wk Low--Dividend TTM2.39MShs Float589.8000Historical High--Div YieldTTM10.82%Amplitude6.0600Historical Low25.7320Avg Price1Lot Size
About Instil Bio Company
Instil Bio, Inc. is a clinical-stage biopharmaceutical company engaged in developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte therapies for the treatment of patients with cancer. The company was founded in August 2018 and is headquartered in Dallas, TX.
Company Profile
SymbolTIL
Company NameInstil Bio
Listing DateMar 19, 2021
Issue Price20.00
Founded2018
CEOMr. Bronson Crouch
MarketNASDAQ
Employees49
Fiscal Year Ends12-31
Address3963 Maple Avenue,Suite 350
CityDallas
ProvinceTexas
CountryUnited States of America
Zip Code75225
Phone1-972-499-3350
Websitehttp://www.instilbio.com
Company Executives
- Name
- Position
- Salary
- Bronson Crouch
- Chief Executive Officer and Chairman of the Board
- 1.58M
- Dr. Sandeep Laumas, M.D.
- Principal Accounting Officer, Chief Financial Officer and Chief Business Officer
- 922.92K
- Dr. Gwendolyn K. Binder-Scholl, M.D.,PhD
- Independent Director
- 57.15K
- Dr. Neil Gibson,PhD
- Lead Independent Director
- 82.65K
- R. Kent McGaughy, Jr
- Independent Director
- 66.15K
- George Matcham, PhD
- Independent Director
- 57.15K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data